Tenofovir: What We Have Learnt After 7.5 Million Person-Years of Use

Tenofovir was licensed for use in patients with HIV in 2001 and since then has become a firmly established anti-retroviral in both guidelines and routine practice. Data have been presented from many pivotal studies—informing on its efficacy, use, and adverse features—and there are also over 7.5 mill...

Descripción completa

Detalles Bibliográficos
Autores principales: Ustianowski, Andrew, Arends, Joop E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471058/
https://www.ncbi.nlm.nih.gov/pubmed/26032649
http://dx.doi.org/10.1007/s40121-015-0070-1